Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine
- Status
- COMPLETED
- Phase
- PHASE3
Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer
- Status
- SUSPENDED
- Phase
- PHASE2
A Study to Evaluate the Efficacy and Safety of Pertuzumab + Trastuzumab + Docetaxel Versus Placebo + Trastuzumab + Docetaxel in Previously Untreated Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1
An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of Pembrolizumab Versus Docetaxel in Participants Previously Treated for Non-Small Cell Lung Cancer (MK-3475-033/KEYNOTE-033)
- Status
- COMPLETED
- Phase
- PHASE3
To Evaluate the Efficacy and Safety of Capecitabine Prior to Surgery in Women With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Ramucirumab (LY3009806) in Combination With Weekly Docetaxel in Participants With Stage IV Non-Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Atezolizumab Compared With Docetaxel in Non-Small Cell Lung Cancer (NSCLC) After Failure With Platinum-Containing Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Darolutamide in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Docetaxel Followed by Provenge in Metastatic Prostate Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Pemetrexed Plus Cisplatin With Concurrent Radiation Therapy Followed by Docetaxel Consolidation in Patients With Inoperable Squamous Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2